Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
- Conditions
- Peritoneal CancerOvarian CancerFallopian Tubes
- Interventions
- Biological: Globo-H-GM2-sTn-TF-Tn-KLH conjugate, plus the immunological adjuvant QS-21
- First Posted Date
- 2010-11-25
- Last Posted Date
- 2017-03-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 26
- Registration Number
- NCT01248273
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
GlowCap Reminder System in Patients With Early Stage Breast Cancer Receiving Adjuvant Endocrine Therapy
- Conditions
- Breast Cancer
- Interventions
- Other: GlowCap device
- First Posted Date
- 2010-11-11
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 8
- Registration Number
- NCT01239251
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center 1275 York Avenue, New York, New York, United States
Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab
- Conditions
- Fallopian Tubes CancerOvarian CancerPeritoneal Cancer
- Interventions
- Biological: bevacizumab and the polyvalent vaccine-KLH conjugate + OPT-821
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2018-06-12
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 22
- Registration Number
- NCT01223235
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
- Conditions
- MelanomaCNS-Spinal CD/MEMBR, NOSSoft TissueSarcomaLymph NodesOvarian CancerBone
- Interventions
- Radiation: IGIMRT using a single dose of 24 GyRadiation: IGIMRT 27 Gy in 3 fractions
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 220
- Registration Number
- NCT01223248
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇮🇹University of Pisa, Pisa, Italy
Evaluation of Respiratory Motion-Corrected Cone-Beam CT in Radiation Treatment of Thoracic and Abdominal Cancers
- Conditions
- Gastric CancerLung Cancer
- Interventions
- Procedure: respiration correlated CT scan
- First Posted Date
- 2010-10-01
- Last Posted Date
- 2018-02-06
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 52
- Registration Number
- NCT01213004
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma
- Conditions
- SarcomaLiposarcoma
- Interventions
- First Posted Date
- 2010-09-27
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 90
- Registration Number
- NCT01209598
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Partial Breast Irradiation (PBI) Using 40 Gy for Select Patients With Early Invasive or Noninvasive Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Radiation: multiple beams utilizing either intensity-modulated or 3D-conformal techniques
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 110
- Registration Number
- NCT01203839
- Locations
- 🇺🇸
Memorial Sloan Kettering Monmouth (Follow-up Only), Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Suffolk (Follow-up Only), Commack, New York, United States
🇺🇸Memorial Sloan Kettering Bergen (Follow-up Only), Montvale, New Jersey, United States
Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome
- Conditions
- Acute Myelogenous LeukemiaMyelodysplastic Syndrome
- Interventions
- First Posted Date
- 2010-09-13
- Last Posted Date
- 2018-05-07
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 113
- Registration Number
- NCT01200355
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Characterization of Rectal Cancer Hypoxia Using pO2 Histography and Immunohistochemistry for Hypoxia-Related Proteins
- Conditions
- Rectal Cancer
- Interventions
- Procedure: Eppendorf hypoximeter
- First Posted Date
- 2010-08-27
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT01189877
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib
- First Posted Date
- 2010-08-26
- Last Posted Date
- 2015-11-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT01189435
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States